CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
Therapy resistance is a significant concern while treating malignant disease. Accumulating evidence suggests that a subset of cancer cells potentiates tumor survival, therapy resistance, and relapse. Several different pathways regulate these purported cancer stem cells (CSCs). Evidence shows that th...
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2023-02-01
|
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2227-9059/11/2/576 |